Corestreet Logo

Kalvista Pharmaceuticals Inc (KALV) Insider Trading

Total insider buys:
  • $45,015,517.47
Total insider sells:
  • $69,954,069.99
Most recent insider trade:
  • Dec. 9, 2024
Most active insider trader:
  • Thomas Andrew Crockett
Trader NameDateTitleAmountPriceTypeTotal Value
Dec. 9, 2024CEO7,627$9.75Sell$74,363.25
Nov. 26, 2024Insider2,187$9.87Sell$21,585.69
Nov. 18, 2024Insider8,077$9.26Sell$74,793.02
Nov. 18, 2024CEO14,400$9.26Sell$133,344.00
Sept. 9, 2024CEO7,352$12.19Sell$89,620.88
Aug. 23, 2024Insider2,135$12.40Sell$26,474.00
Aug. 19, 2024Insider7,102$12.01Sell$85,295.02
Aug. 19, 2024CEO14,215$12.01Sell$170,722.15
June 7, 2024CEO7,465$11.53Sell$86,071.45
May 20, 2024Insider8,088$11.76Sell$95,114.88
May 20, 2024CEO21,959$11.76Sell$258,237.84
Feb. 20, 2024CFO22,802$14.11Sell$321,736.22
Feb. 20, 2024Insider28,288$14.07Sell$398,012.16
Feb. 20, 2024CEO24,888$14.11Sell$351,169.68
Feb. 8, 2024Major Shareholder29,747$14.70Buy$437,280.90
Feb. 6, 2024Major Shareholder4,474$14.74Buy$65,946.76
Jan. 29, 2024Major Shareholder80,600$14.22Buy$1,146,132.00
Jan. 26, 2024Major Shareholder4,174$12.98Buy$54,178.52
Jan. 24, 2024Major Shareholder20,686$12.44Buy$257,333.84
Jan. 22, 2024Major Shareholder67,546$12.55Buy$847,702.30
Jan. 18, 2024Major Shareholder39,680$12.51Buy$496,396.80
Jan. 16, 2024Major Shareholder19,599$12.73Buy$249,495.27
Jan. 11, 2024Insider22,679$13.03Sell$295,507.37
Jan. 10, 2024Major Shareholder47,700$12.67Buy$604,359.00
Jan. 8, 2024Major Shareholder69,184$12.44Buy$860,648.96
Jan. 8, 2024Insider17,221$13.01Sell$224,045.21
Jan. 3, 2024Major Shareholder17,605$12.20Buy$214,781.00
Dec. 29, 2023Major Shareholder6,013$12.49Buy$75,102.37
Dec. 27, 2023CEO30,000$12.02Sell$360,600.00
Dec. 27, 2023Major Shareholder41,514$11.97Buy$496,922.58
Sept. 11, 2023Director18,000$10.50Sell$189,000.00
Aug. 18, 2023CEO14,876$10.73Sell$159,619.48
Aug. 18, 2023Insider8,020$10.73Sell$86,054.60
Aug. 18, 2023CFO13,067$10.73Sell$140,208.91
May 18, 2023CEO5,627$10.14Sell$57,057.78
May 18, 2023Insider2,604$10.14Sell$26,404.56
May 18, 2023CFO4,037$10.14Sell$40,935.18
Feb. 17, 2023CEO6,700$7.66Sell$51,322.00
Feb. 17, 2023Insider3,412$7.66Sell$26,135.92
Feb. 17, 2023CFO4,954$7.66Sell$37,947.64
Nov. 18, 2022CEO1,785$5.44Sell$9,710.40
Nov. 18, 2022Insider1,139$5.44Sell$6,196.16
Nov. 18, 2022CFO722$5.44Sell$3,927.68
Aug. 17, 2022CEO1,797$14.96Sell$26,883.12
March 9, 2022CEO10,000$17.07Sell$170,700.00
Nov. 1, 2021Insider6,000$18.07Sell$108,420.00
Oct. 1, 2021CEO10,000$17.18Sell$171,800.00
Aug. 2, 2021Insider5,000$20.52Sell$102,600.00
July 1, 2021CEO10,000$24.15Sell$241,500.00
June 17, 2021CEO1,067$30.04Sell$32,052.68
First«1 of 3»Last

  • Insiders are both buying and selling Kalvista Pharmaceuticals Inc stock.

  • The insider traders at Kalvista Pharmaceuticals Inc are: Thomas Andrew Crockett, Venrock Healthcare Capital Par, Benjamin L Palleiko, Christopher Yea, Albert Cha, Edward P Feener, Life Sciences Fund Iv (Gp) Sv, Svlsf Iv, Llc, Paul K Audhya, Holdings A/S Novo, Andreas Maetzel, Michael David Smith, Acmp Iv Llc, Rajeev M Shah, David Renzi, and Daniel B Soland

  • The most active insider trader at Kalvista Pharmaceuticals Inc is Thomas Andrew Crockett with 22 trades.

  • Holdings A/S Novo has sold the most Kalvista Pharmaceuticals Inc stock with a total value of $54,105,299.11.

  • Albert Cha has bought the most Kalvista Pharmaceuticals Inc stock with a total value of $29,566,911.61.

  • The most recent insider trade for Kalvista Pharmaceuticals Inc was on Dec. 9, 2024.

  • The single biggest insider buy for Kalvista Pharmaceuticals Inc was from Albert Cha with a total value of $18,000,008.00 on Sept. 10, 2018.

  • The single biggest insider sell for Kalvista Pharmaceuticals Inc was from Holdings A/S Novo with a total value of $26,271,728.12 on Oct. 12, 2017.